S-EPMC8387785 - Survival of castration-resistant prostate cancer patients treated with dendritic-tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56<sup>bright</sup> CD16<sup>-</sup> natural killer cells. - OmicsDI

Unknown

Dataset Information

Survival of castration-resistant prostate cancer patients treated with dendritic-tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56^bright CD16^- natural killer cells.

ABSTRACT:

SUBMITTER: Haque Chowdhury H

PROVIDER: S-EPMC8387785 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature